Pharma Market Access

Market Access

Sanofi to pay back Philippines after Dengue vaccine problems

https://pharmaphorum.com/news/sanofi-reimburse-philippines-dengue-vaccine-scandal/

The power of pharma brands: successful prescription product management

https://pharmaphorum.com/views-and-analysis/pharma-brand-successful-prescription-product-management/

AZ’s asthma drug Fasenra approved in EU

https://pharmaphorum.com/news/azs-asthma-drug-fasenra-approved-eu/

Hunt and Clark refuse to budge from NHS and Business challenges

https://pharmaphorum.com/news/hunt-clark-refuse-budge-nhs-business-challenges/

Early approval: ‘science-based’ Gottlieb wins over sceptics

https://pharmaphorum.com/views-and-analysis/early-approval-science-based-gottlieb-wins-sceptics/

Medicare to fund Abbott’s needle-free diabetes monitor

https://pharmaphorum.com/news/us-government-scheme-covers-abbotts-glucose-monitoring-device/

Spark divides opinion with $850,000 gene therapy

https://pharmaphorum.com/news/spark-gene-therapy-cost/

BI drug named Promising Innovative Medicine in mesothelioma

https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/

NHS should fund GSK’s £526,000 “bubble baby” drug – NICE

https://pharmaphorum.com/news/nhs-fund-gsks-526000-bubble-baby-drug-nice/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com